ILMN Illumina: Earnings growth forecast for next year

Corporate emblem and logo of Illumina, Inc. (ILMN)

Illumina, Inc. (ILMN) maintains global priority in the NGS field, remaining resilient following its spin-off from Grail. This monopoly is sustained by a rigorous patent barrier and a closed ecosystem that prevents equipment switching. A "razor-and-blade" model ensures a steady cash flow from recurring reagent sales. The projected net profit growth rate for n+1 visualizes these expectations, where the parameter value equals 13.60.

Illumina Corp (ILMN): Net earnings per share growth forecast for next year from 07/04/2022 to 11/17/2026

Analytical breakdowns and data insights for company Illumina Inc (ILMN)

- price and consensus price forecast:
Comprehensive company analysis:illumina.com, ILMN
Brand item of Illumina

Conservative capital requires high transparency of projected cash flows to ensure portfolio stability. This indicator measures analyst consensus expectations for net earnings per share growth rates in the coming year. For Illumina, Inc. (ILMN), this calculation is critical during the transition from limited scientific budgets to the high-margin oncology diagnostics market. By analyzing forward EPS dynamics, an investor determines the timing of a market trend reversal.

Competitor analysis

A (agilent.com) - Earnings growth forecast for next year|DGX - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year EXAS|RVTY (Revvity) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year bio-rad.com BIO|NNNN: Projected earnings per share growth rate for next year|Sotera Health Corp - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year QuidelOrtho QDEL|OPK (OPKO Health) - Expected earnings per share growth for next year|Expected net earnings per share growth next year CareDx, Inc. (CDNA)|Expected earnings per share growth for next year MRVI|Expected net earnings per share growth next year Fulgent FLGT|Net earnings per share growth forecast for next year Standard BioTools Inc. (LAB)|CTKB (Cytek Biosciences, Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year OSUR (OraSure Corp)|Consensus forecast of earnings per share growth for next year Exagen Inc. (XGN)|MDXH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Lucid Diagnostics Inc LUCD|PRE (Prenetics Global Ltd) - Expected earnings per share growth for next year|Expected earnings per share growth for next year Insight Molecular|TRIB (Trinity Biotech) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year PRPH|Earnings growth forecast for next year AIMD|Projected earnings per share increase next year CODX|Net earnings per share growth forecast for next year Heart Test Laboratories HSCS|BMRA: Projected earnings per share growth rate for next year|CDIO - Net earnings per share growth forecast for next year|Onconetix Corp (ONCO) - Expected earnings per share growth for next year|VRAX (Virax Biolabs Group Ltd) - Expected earnings per share growth for next year|Expected net earnings per share growth next year Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Earnings growth forecast for next year|AXDX - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year centogene.com (CNTG)|Consensus forecast of earnings per share growth for next year Enzo Biochem|Consensus forecast of earnings per share growth for next year FRES|Net earnings per one share growth forecast for next year GTG Labs|23andMe Holding Co - Earnings growth forecast for next year|PMD - Earnings growth forecast for next year